PROTEASOME INHIBITORS SENSITIZE GLIOMA CELLS AND GLIOMA STEM CELLS TO TRAIL-INDUCED APOPTOSIS BY THE CLEAVAGE AND DOWN-REGULATION OF PKC EPSILON